Uncategorized

University of Missouri Conducts First In-Person Clinical Trial for Nuclear Medicine Breakthrough Device

[University of Missouri] In a major leap for cancer care at the University of Missouri, the School of Medicine and MU Health Care have launched their first clinical trial using a leading-edge therapy manufactured on campus at the university’s research reactor.

Activated ATF6α Is a Hepatic Tumor Driver Restricting Immunosurveillance

[Nature] Scientists demonstrated the function of ATF6α as an endoplasmic reticulum (ER)-stress-inducing tumor driver and metabolic master regulator restricting cancer immunosurveillance for hepatocellular carcinoma, in contrast to its well-characterized role as an adaptive response to ER stress.

Diploid Hepatocytes Resist Acetaminophen-Induced Liver Injury through Suppressed JNK Signaling

[Cell Death & Disease] Researchers investigated how hepatocyte ploidy affects susceptibility to acetaminophen-induced liver injury by comparing diploid-enriched liver-specific knockout of E2f7/E2f8 and polyploid-enriched control mice.

EP300 Promotes Hepatocellular Carcinoma Proliferation, Migration, and In Vivo Tumorigenicity Revealed by Integrated Experimental, and Bioinformatic Analyses

[Journal of Translational Medicine] Investigators found that EP300 is consistently upregulated in hepatocellular carcinoma and supports malignant phenotypes in vitro and in vivo.

Targeted Degradation of Lin28B Using Pre-Let-7-PROTACs for Hepatocellular Carcinoma Therapy

[Journal of Medicinal Chemistry] The authors confirmed that pre-let-7-PROTACs reduce tumor stemness by degrading Lin28B, offering a promising therapeutic approach for hepatocellular carcinoma.

TGFBI Promotes Liver Fibrosis through Remodeling the Profibrotic Microenvironment by a Positive Feedback Regulatory Loop

[Communications Biology] Researchers showed that transforming growth factor-beta-induced protein (TGFBI) promotes liver fibrosis in male C57BL/6 mice. TGFBI was upregulated in fibrotic livers and derived from non-parenchymal cells.

Liver Fibrosis and Type 2 Diabetes Modulate Postprandial Incretin and Glucagon Responses in Fatty Liver Disease

[Journal of Physiology and Biochemistry] Scientists uncovered how fibrosis and diabetes interact to modulate enterohepatic communication, providing insights into metabolic-associated steatotic liver disease pathophysiology and identifying potential therapeutic targets for disease management.

Direct Analysis of Hepatic Stellate Cells with Flow Cytometry in Specimens Derived from the Human Liver

[International Immunology] Investigators aimed to establish a robust methodology to analyse primary hepatic stellate cells in human liver specimens with flow cytometry.

Applications and Limitations of Pluripotent Stem Cell-Derived Liver Organoids

[Chinese Medical Journal] Scientists provide an overview of liver organoid development and discusses their applications in liver regeneration, disease modeling, drug screening, toxicity assessment, organ transplantation, and regenerative medicine.

Sensory Neurons Drive Immune Exclusion by Stimulating a Dense Extracellular Matrix in the Breast Cancer Tumor Microenvironment

[Cell] The authors deciphered that sensory neurons, the dominant neuron type in the triple negative breast cancer ecosystem, drive the immune-excluded tumor microenvironment by stimulating a dense extracellular matrix.

Matrix Stiffness Governs Fibroblasts’ Regulation of Gingival Immune Homeostasis

[Advanced Materials] Scientists hypothesized that ECM softening in periodontal disease contributes to inflammation by dysregulating gingival fibroblasts.

Extracellular Matrix Mediates Circulating Tumor Cell Clustering in Triple-Negative Breast Cancer Metastasis

[Nature Communications] Researchers showed that the ECM component hyaluronan mediates adherens junction-independent circulating tumor cell clustering in triple-negative breast cancers.
spot_img